AUG 08, 2016 11:52 AM PDT

Immune-Mediated Neuropathies Caused By Autoantibodies

WRITTEN BY: Kara Marker
Whether chronic or acute, patients with inflammatory nerve disorders are often out of luck for a quick diagnosis or accurate treatment. A new study could soon contribute to improving the circumstances of these patients though: from the University of Wurzburg, researchers are looking at a specific protein as the culprit for some cases of immune-mediated neuropathy.
Credit: faculty.ivytech.edu
Inflammatory nerve disorders develop quickly, often resulting in severe paralysis. There are currently zero diagnostic tests in existence that can accurately diagnose an immune-mediated neuropathies. Patients are then often treated with corticosteroids or antibodies that that have little to no therapeutic effect. Based on results from their current study, published in the journal Brain, and previous studies with similar findings,  Wurzburg scientists recommend a new approach.

In a study of 35 patients with a chronic inflammatory nerve disorder, called chronic inflammatory demyelinating polyneuropathy (CIDP), and 22 patients an acute disorder called Guillain-Barre syndrome, researchers looked for any evidence of autoantibodies targeting a specific component of the nerve fiber called Caspr. This protein helps to build the “Nodes of Ranvier,” a nerve fiber structure that serves as a gap between sections of myelin sheath that forward nerve impulses. 

The myelin sheath acts as an “electrical insulator” that propagates nerve impulses to the attached Nodes of Ranvier, and when antibodies attack Caspr, the structure of the nodes is destroyed and nerve function is rendered drastically impaired.
Credit: www.keyword-suggestions.com
Wurzburg researchers found autoantibodies targeting Caspr in the blood of one patient with CIDP and one patient with Guillain-Barre syndrome. With confirmation of the causation behind these patients’ disease, the researchers successful administered rituximab to inhibit antibody function and reduce the symptoms of their neuropathy. Rituximab is a CD20-directed cytolytic antibody used for treating patients with conditions like non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis.

Antibodies targeting Caspr proteins may not be the full answer to immune-mediated neuropathies, but researchers from the study believe that antibodies targeting other nerve fiber-related proteins could fill in the gaps of causation. In fact, Caspr is just the third protein in this area of the Nodes of Ranvier for which autoantibodies have been identified. The other two proteins involved with immune-mediated neuropathies include Contactin-1 and Neurofascin-155. Scientists are starting to see that depending on which nerve fiber protein is being targeted by autoantibodies, a patient will exhibit different features.
 
In the future, researchers plan to conduct blood tests for known autoantibodies that target nerve fiber-related proteins, as well as continue to search for other proteins being targeted that cause neuropathies.
 


Sources: Therapeutic Advances in Neurological Disorders, University of Wurzburg, Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 6th edition, Gene.com
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 14, 2019
Microbiology
NOV 14, 2019
In Space, Dormant Viruses Can Reactivate
Some astronauts have lived onboard the International Space Station for hundreds of days. Researchers are learning more about the things that can happen in that time....
NOV 14, 2019
Space & Astronomy
NOV 14, 2019
Spaceflight Activates Dormant Herpes Viruses in Astronauts
Modern science is teaching us that long-term exposure to microgravity, such as living on the International Space Station from ten days to several months at...
NOV 14, 2019
Cell & Molecular Biology
NOV 14, 2019
Learning More About the Causes of Endometriosis Pain
Endometriosis can be an extremely painful disorder that significantly impacts quality of life....
NOV 14, 2019
Drug Discovery & Development
NOV 14, 2019
Researchers Can Now Reverse Skin Cancer
Ten years ago, just 5% of people with advanced melanoma (skin cancer) lived more than five years after being diagnosed. Now however, researchers from the I...
NOV 14, 2019
Infographics
NOV 14, 2019
Do You Know Your Measles Immune Status?
Measles outbreaks continue to make news around the world. The Centers for Disease Control and Prevention update on a weekly basis the number of measles cas...
NOV 14, 2019
Immunology
NOV 14, 2019
Algorithm Predicts Response to HIV Immunotherapy
Blood samples from HIV patients produced the data necessary for two scientists to build a mathematical model for predicting how HIV patients will respond t...
Loading Comments...